| AD | Alzheimer’s disease |
| Ag | Antigen |
| APC | Antigen presenting cell |
| BDNF | Brain derived neurotrophic factor |
| CNS | Central nervous system |
| CTL | Cytotoxic T-lymphocyte |
| DA | Dopamine |
| DAMPs | Danger-associated molecular pattern molecules |
| DC | Dendritic cell |
| EAE | Experimental autoimmune encephalomyelitis |
| GLUT | Glutamate |
| HD | Huntingtin’s disease |
| HDAC6 | Histone deacetylase 6 |
| IFNγ | Interferon gamma |
| IL-1β | Interleukin 1 beta |
| IP | Immunoproteasome |
| Meth | Methamphetamine |
| MHC | Major histocompatibility complex |
| MS | Multiple sclerosis |
| mTOR | Mammalian target of rapamycin |
| NF-κB | Nuclear factor K beta |
| PD | Parkinson’s disease |
| Rab GTPase | Gtp bound ras proteins in brain |
| SNARE | Soluble Nsf attachment protein receptor |
| SP | Standard proteasome |
| SQSTM1 | Sequestosome-1 |
| SV | Synaptic vesicle |
| TCR | T-cells receptor |
| TLR4 | Toll-like receptor 4 |
| TNFα | Tumor necrosis factor alpha |
| UPS | Ubiquitin proteasome |